Gerald L. Andriole, Jr., MD, reviews the history of conventional transrectal ultrasound (TRUS) guided biopsy and the limitations of this technique that remain in the modern era. He then discusses current and emerging efforts to improve image guided prostate biopsies.
Read More
Gerald L. Andriole, MD, FACS, asserts that the fluciclovine PET-CT scan has a significant impact on the management of patients with biochemically recurrent prostate cancer.
Read More
Gerald L. Andriole Jr., MD, addresses the burden of burnout in medical practice, particularly in the urology specialty, and its effect on physicians, patients, and organizations. He then outlines actions individuals, healthcare organizations, and national institutions can take to alleviate this problem.
Read More
Gerald L. Andriole Jr., MD, who served on the cause of death ascertainment committee for the Prostate Intervention Versus Observation Trials (PIVOT), discusses PIVOT and criticisms to the trial design. Additionally, he analyzes similar trials testing definitive versus non-definitive treatment in low-risk disease.
Read More
Gerald L. Andriole, Jr., MD, discusses the limitations and successes in the design of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) and European Randomized Study of Screening for Prostate Cancer (ERSPC) trials. He also emphasizes the importance of patient selection in PSA screening and utilizing other diagnostic methods.
Read More